LobbyingCambia Health Solutions lobbying by quarter
Cambia Health Solutions's latest lobbying report covers Q2 2026, at $700K. The four quarters Q4 2025–Q3 2026 total $2M. Its first report covers Q3 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Cambia Health Solutions
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $2M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2022 | $550K | 1 |
| Q4 2022 | $570K | 1 |
| Q1 2023 | $590K | 1 |
| Q2 2023 | $650K | 1 |
| Q3 2023 | $570K | 1 |
| Q4 2023 | $620K | 1 |
| Q1 2024 | $600K | 1 |
| Q2 2024 | $650K | 1 |
| Q3 2024 | $660K | 1 |
| Q4 2024 | $640K | 1 |
| Q1 2025 | $620K | 1 |
| Q2 2025 | $630K | 1 |
| Q3 2025 | $680K | 1 |
| Q4 2025 | $630K | 1 |
| Q1 2026 | $630K | 1 |
| Q2 2026 | $700K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$5M · 16 reports
- Medicare and Medicaid$5M · 16 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES16 reports
- SENATE16 reports
- Centers For Medicare and Medicaid Services (CMS)14 reports
- Health & Human Services, Dept of (HHS)13 reports
- Executive Office of the President (EOP)1 reports
- Labor, Dept of (DOL)1 reports
- Treasury, Dept of1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseCambia Health Solutions | $10M | 16 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| RYNE CARNEY | Intern - Rep. Ed Perlmutter | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $700K |
| 04/16for Q1 | In-house | $630K |
| 01/16for Q4 2025 | In-house | $630K |
| 25/10/20for Q3 2025 | In-house | $680K |
| 25/07/18for Q2 2025 | In-house | $630K |
| 25/04/21for Q1 2025 | In-house | $620K |
| 25/01/21for Q4 2024 | In-house | $640K |
| 24/10/17for Q3 2024 | In-house | $660K |
| 24/07/19for Q2 2024 | In-house | $650K |
| 24/04/12for Q1 2024 | In-house | $600K |
| 24/01/22for Q4 2023 | In-house | $620K |
| 23/10/19for Q3 2023 | In-house | $570K |
| 23/09/07for Q3 2022 | In-house | $550K |
| 23/07/20for Q2 2023 | In-house | $650K |
| 23/04/18for Q1 2023 | In-house | $590K |
| 23/01/18for Q4 2022 | In-house | $570K |